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 the pH within a desired range is a very common practice in chemical, biochemical and biological studies. 
substituted aminosulfonic acids, usually known as Good’s buffers, although widely used, can complex 
gical systems. The present work reviews, discusses and updates the metal complexation characteristics of 
ble buffers. In addition, their impact on biological systems is also presented. The influences of these buffers 
ogical, biochemical and environmental studies, with special focus on their interaction with metal ions, are 
wed. Using chemical speciation simulations, based on the current knowledge of the metal–buffer stability 
ost adequate buffer to employ for a given metal ion is presented.The proper maintenance of the pH is very important in several
chemical, biochemical and biological applications. The pH
affects the rate of chemical reactions, the efficiency of chemical
separations, and the recovery and purity of products. Results
given by analytical techniques, such as electrophoresis, chro-
matography, voltammetry and immunoassays, also depend on
the control of the hydrogen ion concentration. In biological
studies, the pH inuences cell metabolism.
Proteins may suffer changes in their shape in response to
modication of the pH of the surrounding solution. This effect
can be explained due to the presence of carboxyl and amine
functional groups, whose level of ionization is inuenced by the
pH of the solution. Thus, the changes of pHmodify electrostatic
interactions between charged functional groups of the amino
acids and consequently the three-dimensional structure (shape)
of the protein. Since the function of a protein is dependent on
its shape, a deep change of pH can lead to the disruption of
protein structure (denaturation) and loss of its function.
1. Introduction In a similar way, the pH affects enzymatic rates. This aspect
is of particular importance, since during enzymatic reactions
protonsmay be consumed or released. Thus, it is very important
to maintain the proton concentration in solution without
interference with the enzymes. A constant hydrogen concen-
tration is also important in speciation studies in water. As an
example, Wang et al.1 have demonstrated the importance of
different factors, including pH, on speciation and availability of
aluminium in public water.
In a general way, the control of the pH is achieved by adding
an appropriate buffer to the system, according to the desired pH
range. However, buffers can affect biological systems at an
organism or a biochemical level. For instance, the buffer can
inuence cell growth,2 modify lipid membrane interaction3 and
enzyme activity (see below) and form radical species.4 The
inuence of specic buffers in different cellular and metabolic
processes is detailed in subsections 3.1.1.–3.1.3.
Traditional buffers such as phosphate, citrate, borate and
succinate have some disadvantages when they are used in
biological or complex systems. Phosphate has a poor buff-
ering capacity above pH 7.5 and is an active participant in
many biochemical processes. Phosphate inhibits carboxy-
peptidase, fumarase, urease, many kinases and dehydroge-
nases as well as enzymes with phosphate esters as
substrates.5 Phosphates also demonstrate complexing capa-
bilities with polyvalent cations and can therefore inhibit a
series of metal ion-dependent biochemical reactions.6 Citrate
and succinate form complexes with various cations.6 Imid-
azole is used to prepare buffers in the pH range of 6.2–7.8 at
25 C and is also a chelator of various divalent cations.6 Tris is
(7) nally, they should be easy to prepare and inexpensive.
Zwitterionic N-substituted aminosulfonic acids seemed to
meet most of the criteria. These compounds, which are 
neutral molecules with a positive and a negative electrical 
charge, have advantages over the traditional buffers, espe-
cially due to the membrane impermeability and stability. 
However, none of the buffers completely fulls all the criteria 
proposed by Good. Buffers are used under the assumption 
that they have no or very little interaction with metal ions 
present in environmental or biological studies. In the last 
decades, the increasing number of reports on buffer com-
plexing properties with metal ions conrms otherwise. Results 
in similar experiments using different buffers have produced 
dissimilar results.12–14
The aim of this work is to provide information for 
choosing an adequate buffer with full knowledge of their 
complexing properties, when it comes to systems with metal 
ions. Because the knowledge about the complexation 
between buffers and metal ions  is necessary, this review
summarizes the stability constants already reported and tries 
to predict possible complexation of metal–buffer systems 
that are still not described in the literature. Additionally, 
studies where biological effects induced by buffers were 
described are also critically reviewed and discussed.
not a very efficient buffer below pH 7.5 and displays a 
potentially reactive primary amine, which oen acts as an 
inhibitor. It has an appreciable solubility in organic solvents; 
this property allows it to penetrate in biological membranes7 
and form complexes with several metal ions.8 Tris is toxic for 
many mammalian cells due to its ability to penetrate into 
cells.9 Glycylglycine is an expensive buffer that only works 
well above pH 8.0 and complexes with cations. Borate buffer 
complexes with a wide variety of important respiratory 
metabolites and other organic compounds as well.7 In addi-
tion, many side effects cannot be predicted and buffers may 
uncouple or inhibit or modify reactions by mechanisms not 
yet understood.
In 1966, Good and co-workers10 proposed twelve pH buffers 
to be used in biological studies in substitution of the traditional 
ones. Eight more buffers were proposed in subsequent 
studies.6,11 Their proposal was based on the following criteria:
(1) buffers should cover pH values between 6 and 8, since 
this is the pH region where fewer buffers were available and 
most biological reactions take place;
(2) buffers should have maximum water solubility to allow 
the use of concentrated stock solutions and minimum lipid 
solubility, making them impermeable to membranes;
(3) a minimal inuence of the temperature, ionic strength or 
buffer concentration on the pKa should occur;
(4) buffers should not form complexes with cations, or, if 
they do, the complexes should be soluble and the binding 
constants known;
(5) the buffers should be stable, not metabolized and should 
not act as enzyme inhibitors or substrate analogues;
(6) they should not absorb light above 240 nm, and partic-
ularly not in any region that would be used in spectrophoto-
metric assays;2. Families of Good’s buffers and
metal–buffer interactions
The buffers proposed by Good et al.10 in his rst paper were:
MES, ADA, PIPES, ACES, cholamine, BES, TES, HEPES, N-(2-
acetamido)glycine, tricine, glycinamide hydrochloride and
bicine.
Two more published documents from Good and co-
workers6,11 proposed eight additional buffers: MOPSO, MOPS,
DIPSO, TAPSO, POPSO, HEPPSO, EPPS and TAPS, which raised
the number of Good’s buffers to twenty. Over the years, some
more buffers have been suggested for biological application.
More recently, Thiel et al. developed new buffers with butane
containing side chains: MOBS, TABS, HEPBS and CABS,
extending the useful buffering pH range into the more alkaline
range.15
Nowadays, the Sigma catalogue16 dedicates to them a special
section, which is constituted by more than thirty biological
buffers. Other companies also supply these buffers, such as
Fischer Scientic17 and VWR.18 The buffers are listed in Fig. 1,
where their pH buffering range is posted. The pH buffering
range is based on the protonation constant(s) dened by:
xH+ + Ln# HxL
(nx)
with
Ka ¼

HxL
ðnxÞ
½Hþx½Ln ;
where L stands for the buffer and HxL stands for the protonated
buffer. The formation constants for metal complexes are
dened by:
pMn+ + qLm + roH# MpLq(OH)r
(p$nq$mr)
with
bpqr ¼
h
MpLqðOHÞrðp$nq$mrÞ
i
½Mnþp½Lmq½OHr
where L retains the same meaning as above and MpLq(OH)r
stands for metal complexes with a buffer. In the case of the
formation of complexes involving the protonated form of a
ligand, e.g. MLH, the OH should be replaced by H+.2.1. Morpholinic family
MES, MOPSO, MOPS and MOBS are N-substituted amino-
sulfonic acids with a morpholinic ring (Table 1).
There is no evidence of complex formation for MES, MOPSO
and MOPS with the main metals present in environmental and
biological studies. MES, MOPSO and MOPS have shown no
signicant complexation with Cd and Pb.19 Soares et al.19,20
showed that these three compounds also do not complex with
Cu nor Zn. Mash et al.21 concluded that no binding occurred
between Cu and MES or MOPS. Accordingly, Renganathan and
Bose7 did not nd differences in the Cu inhibition of photo-
system II electron transport in the presence of MES, concluding
 
Fig. 1 List of buffers analyzed in this work and their pH range. Red – not suitable for general use; green – suitable for general use.
Table 1 Families of buffers and their respective structures
that no complexation occured. However, conicting studies can 
be found. Anwar and Azab22 presented metal–buffer stability 
constants for MOPSO (Cu, Ni) and MOPS (Cu, Ni, Mn, Zn, Co). 
The same research group23 considered the complexation of MES 
with Cu, Ni, Co, Zn, Ca, Mg and Mn and proposed stability 
constants for the formation of these complexes. Wyrzykowski 
et al.24 agrees with the formation of MES complexes with Ni and 
Co, with ML constants signicantly lower than the ones deter-
mined by Azab and Anwar;23 however, ML(OH)2 complexes were 
also included in the model, which can explain such differences. 
Complexes of Fe(III) and Cr(III) with MES, MOPSO, MOPS and 
MOBS were studied by Gupta et al.25 and Taha et al.26 who 
admitted that when these buffers are used in media where metal 
exists, interferences may occur due to metal complex formation. 
In the studies conducted by Johnston and Singer,27 the results 
indicate that no complexation occurs between MES and Fe(II).
Despite these reports of complexation, most of the authors 
agree that there is no evidence of signicant bonding to metals 
and several studies specically chose MES or MOPSO due to 
their inability to interfere with the most important metals in 
biological and environmental applications.28–30 In fact, for MES, 
the analytical techniques used by Soares et al.19,20 and by Mash 
et al.21 are more sensitive than those used by Azab.23 Addition-
ally, the soware used for the renement of the potentiometric 
data collected by Azab did not contain graphical analysis. In this 
case, the renement of the complexation models is guided only 
by statistical parameters, which may lead to false-positives. 
Furthermore, the data from Renganathan and Bose7 and John-
ston and Singer27 support the idea that MES is a non-
complexing buffer. For both MOPSO and MOPS, the same 
conclusions can be drawn, which means that these compounds 
are capable of buffering solutions within pH 6.20 to 7.60 and 
6.50 to 7.90 (Fig. 1), respectively, without any or signicant 
interaction with metal ions in solution. Given its structural 
similarity with MES and MOPS, a similar behaviour is expected 
for MOBS which has buffer capabilities between pH 6.90 to 8.30.2.2. Piperazinic family
PIPES, HEPES, POPSO, EPPS, HEPPSO and HEPBS contain a 
piperazinic ring (Table 1). Like MES and MOPS, PIPES and 
HEPES are frequently used in environmental, analytical and 
biological studies due to their lack of ability to complex with 
metal ions. There are evidences that PIPES and HEPES do not 
complex with Cu31,32 and slightly complex with Pb.33 Rengana-
than and Bose7 also concluded about the negligible bonding 
between Cu and HEPES and Hoffman et al.34 obtained a similar 
result about Cd and PIPES. However, stability constants for 
PIPES complexes with Cu, Ni, Co and Zn24,35 and HEPES 
complexes with Cu, Zn, Pb and Cd36,37 have been described in 
the literature. Yu et al.38 also demonstrated formation of Cu(II)–
HEPES complexes while PIPES shows no evidence of bonding 
with Cu. It is worth noting that the constants for Ni and Co are 
very similar, in disagreement with the general trend where Ni(II) 
presents larger stability constants than Co(II). Also, most work 
made use of potentiometric data for the renement of data. As it 
was discussed above, the application of this technique forcomplexation studies with these types of compounds leads to
some doubt about these constants, evenmore when other, more
sensitive techniques, were applied to some of these and other
cases and no complexation was detected. Therefore, PIPES and
HEPES are, together with MES and MOPSO, more adequate to
substitute Tris and phosphate than other zwitterionic buffers.39
While Azab et al.64 shows that HEPPSO complexes with metal
ions, the work performed by Soares and Conde,33 Anwar37 and
Mash et al21 demonstrated that no complexation occurs for
HEPPSO, except that Mash was able to determine a stability
constant for the HEPPSO–Cu(II) system. The additional hydroxyl
group in HEPPSO may be responsible for this slightly different
behaviour. Therefore, in the case of HEPPSO with Cu, special
attention is needed if one wants to use it to buffer Cu(II) solu-
tions. Apart from this case, this buffer is suitable for use with
other metals in solution.
EPPS (Table 1) is described to complex weakly with Cu and
Pb and does not form complexes with Zn and Cd.40 However,
considering the structural similarities between EPPS and
HEPES, it seems that EPPS is possibly a good buffer to be used
in media with metal ions. There are not many studies about
complexation of POPSO; however, it was described that it binds
with Cu.32 No other complexation works studying the interac-
tion between this buffer and other metal ions were found in the
literature.
For HEPBS (Table 1), no complexing properties are described
in the literature. An analysis of its structure reveals that it is very
similar to that of HEPES and EPPS; therefore, the same chem-
ical behaviour is expected. Thus, HEPBS is an appropriate
buffer to be used in media with metal ions.
2.3. Bis(2-hydroxyethyl)amine family
The bis(2-hydroxyethyl)amine family includes bis-Tris, BES,
DIPSO, TEA and bicine (Table 1). For bis-Tris, DIPSO and TEA,
there are stability constants described in the literature for most
of the metals included in environmental and biological
studies.8,41–45 In the case of BES, the only evidence of complex-
ation found in the literature corresponds to Cu and Co.8,46
Bicine also complexes with most of the metals studied.8,47 Based
on their complexation properties, the use of buffers from this
family is not advisable in environmental and biological studies
containing metals, unless stability constants are taken into
consideration (see below, Section 3.1.7.1.).
2.4. Tris family
Tris, TES, TAPSO, TAPS, TABS, tricine and BTP belong to the
Tris group (Table 1). TES, TAPSO and tricine have stability
constants described for most of the metals.8,23,25,26,43,48–54
Renganathan et al.7 found interferences in Cu inhibition of
photosystem II electron transport due to bonding between Cu
and TES, Tris and tricine. For TAPSO and TAPS, there is
evidence of complexation with Cd, Co, Cu, Pb, Ni and
Zn.41,43,49–51,55,56 Muzikar et al.57 warned against the use of TAPS
in buffering electrolytes and presented stability constants with
Ca, Mg, Sr and Ba, but the values are extremely low. In the case
of TABS, only values for Fe and Cr were found in the
literature,25,26 but due to its structure (Table 1), it probably 
complexes with other metals. Fisher et al. studied the 
complexation properties of Tris with a large array of divalent 
metal ions.58
BTP is the only buffer mentioned in this paper that has two 
well dened protonation constants due to the presence of two 
secondary amines. It is a strong complexing agent as was shown 
in studies with Cd, Co, Cu, Ni, Pb and Zn.46,53,542.5. Cyclohexylamino family
The cyclohexylamino family comprises CHES, CAPSO, CAPS and 
CABS (Table 1). Published complexation studies have only been 
described for CHES.23 Data about the complexation of the other 
three compounds was not found in the literature. A previous 
work of our team demonstrates that CAPSO, CHES and CAPS 
display weak complexation capabilities with Cu, Pb, Cd and Zn. 
CAPSO, with its hydroxyl moiety, presents the higher complex-
ation capability. Their buffering capacity ranges between pH 
8.60 and 11.40 (Fig. 1), which usually excludes them as the rst 
choice in biological and environmental studies, unless higher 
pH is desired.2.6. Acetamido family
ADA and ACES, both belonging to the acetamido family (Table 
1), form complexes with most of the common metals in 
studies.8,59 In fact, ADA has been used as a complexing agent to 
remove metals from contaminated soils, namely Pb and Cd,60,61 
proving its inadequacy to be used as a buffer in the presence of 
metals without taking into account the stability constants.2.7. Propanol family
This family comprises AMPD, AMPSO and AMP buffers (Table 
1). Data is found related to complexation between AMP and Cu, 
Cd and Ni.8 On the other hand, there are no published studies 
concerning the complexation of AMPD. However, a previous 
work of our team (data not published) demonstrates that AMPD 
has some complexation capabilities with Pb, Cd and Zn. Studies 
about AMPSO complexation have shown that this buffer has the 
ability to bind with Ca, Co, Cu, Pb, Mg, Mn and Ni.42,43,62–652.8. Complexation studies between Good’s buffers and 
lanthanides and others ions
Complexation studies between buffers and other metal ions 
that are not so common have been performed and are useful 
when dealing with these specic elements and species. Azab 
et al.66 and Orabi et al.67 determined the stability constants of 
the formation of the complexes between lanthanides and 
several Good’s buffers. The complexation of Tris with La, Ce and 
Th was studied by El-Roudi and co-workers.68 El-Gahami 
et al.69,70 studied the complexation of MES and MOPSO with 
dibutyltin(IV) and dimethyltin(IV) cations.3. Employment of Good’s buffers in
biochemical, biological and
environmental studies
Good’s buffers have been used in many biological studies since
the time they were rst described10 and chemical suppliers
made them easily available for use in the laboratory. Table 2
presents examples of the applications of Good’s buffers, such as
in biomolecular, biochemical, molecular and cellular biology,
toxicology and environment studies, where a wide array of
techniques, such as chromatography,71–74 electrophoresis,75–78
spectrophotometry79–81 and X-ray crystallography81,82 were used.
Good’s buffers seem to be adequate for toxicity studies. It
was shown that MES buffer is not toxic to the yeast S. cer-
evisiae.83 No toxic effects of DIPSO and HEPES on the alga
Amphidinium carterae were observed.84 In a similar way, no
toxicity for small crustaceans (commonly called water eas)
Daphnia magna and Daphnia pulex was reported when HEPPSO
and HEPES were used as buffers.853.1. Are Good’s buffers so good?
When choosing a buffering agent, among other requirements
(such as its solubility and ionic strength), the pKa value of the
buffer, which should be close to the pH in which the biological
study will be carried out, should be taken into account, together
with the compatibility of the buffer with the reaction system,
namely the impact on cell structures and macromolecules,
complexing and redox characteristics.
Although there is no perfect buffer, i.e., one that displays all
the characteristics enumerated by Good (Section 1), the zwit-
terionic N-substituted aminosulfonic acids seem to meet most
of them. However, it should be emphasized the importance of
the knowledge of the potentialities and limitations of the
different buffers, which must be taken into account in the
moment of the buffer selection. In other words, particular care
should be taken when selecting the buffer for a given experi-
ment, since the buffer may interact with the different compo-
nents of the system under study. In many cases, for instance in
enzymatic studies, buffers are usually present at higher
concentration than the other components in reactionmixtures.5
Thus, any kind of buffer interaction can deeply affect the
results.
3.1.1. Impact of buffers on cell growth and survival.
Different buffers can be added to the culture medium in order
to control the pH. MES is not metabolized by bacteria and
eukaryotic cells; therefore, it is oen used to prepare buffered
culture media. AlthoughMES can be toxic at high concentration
(>10 mmol l1),86 this buffer has been also used in culture
media for plant cells.87 ACES, MOPS andMOPSO were employed
as a buffer component of charcoal yeast extract medium for the
optimal growth of Legionella pneumophila, without causing the
growth inhibition observed with some inorganic buffers.88 MES,
MOPS and bis-PIPES seem to be appropriate buffers for
mammalian cell culture.2 It was also described that chilled
bovine embryos, stored for 7 days in a medium supplemented
Table 2 Examples of biological uses of Good’s buffers
Field Study Buffer
Biomolecular/biochemical/molecular
biology
Spectroscopic and potentiometric studies of Cu(II) complexes175 MOPS
Reduction of some Pt(IV) complexes with biologically important sulfur-donor
ligands176
HEPES
Inhibition of gelatinases by captopriland lisinopril177 Tris
Nitrogenase electron transfer mechanism178 MOPS
Modulation of connexin channel activity92 MES, HEPES and TAPS
Characterization of P-type ATPase in Thermus thermophilus179 Tris
Measurement of high-density lipoprotein-subclass cholesterol35 BES
Separation of nucleic acids and proteins by electrophoresis9,96 Tris, MOPS and tricine
Measurement of pBR32 plasmid DNA cleavage by the restriction enzyme
EcoRV103
Tris, BTP, BES and HEPES
Cellular biology Cold storage of isolated hepatocytes180 BES
Effect of auxin on the osmoregulation of Avena sativa protoplasts181 MES and BTP
Control of culture media pH2,87,88 MES, ACES, MOPS and
MOPSO
Fluorescent cell labelling182 HEPES
Toxicology Cu and Zn toxicity to Daphnia magna and Pseudokirchneriella subcapitata163 MOPS
Cu toxicity to Amphidinium carterae183 HEPPSO and POPSO
Cu, Ni, Cd and Pb toxicity to Saccharomyces cerevisiae173,184–186 MES
Evaluation of bacterial endotoxins72 BES and Tris
Environment Cu removal by Chlamydomonas reinhardtii170 MES
Cu, Ni and Zn removal by Saccharomyces cerevisiae172,187,188 MES
Arsenate and phosphate adsorption by goethite-based adsorbent189 HEPES
Immobilization of U(VI) by biological oxidation of U(IV)165 HEPESwith HEPES, had much higher survival than embryos stored in 
the same medium with TES, PIPES, MOPS or EPPS.89
3.1.2. Interaction of buffers with cell membranes. MES, 
MOPS and HEPES can modify lipid interactions.3 HEPES affects 
membrane potentials in neuronal cells,90 MOPS can inuence 
the thickness and barrier properties of rat endothelial surface 
layers91 and MES, HEPES and TAPS, when in the protonated 
form, inhibit the connexin channel activity in rat liver cells.92 
Animal cells seem to be more sensitive to the presence of the 
buffer, most likely due the absence of a cell wall. In fact, a study 
using as a cell model the yeast Saccharomyces cerevisiae revealed 
the maintenance of the membrane integrity when the cells were 
incubated in 10 mM MES at pH 6.0.83
3.1.3. Interaction of buffers with macromolecules. Buffers 
are used in most in vitro reaction systems in order to keep 
constant the pH of the solution. Different works described the 
interaction of the buffer with macromolecules such as proteins 
and nucleic acids.
MES, MOPS and MOPSO interact with the peptide backbone 
of bovine serum albumin, leading to a net stabilization of the 
protein.93 In a study using as a model the naturally aggregating 
Escherichia coli protein (RecA) (which among other functions, 
performs DNA repair), it was found that the buffers (HEPES, 
MES and Tris) had minimal effect on nucleotide binding.94 
However, the interaction of the buffers with the protein had 
signicant effects on their thermal stability, unfolding transi-
tions and the dsDNA nucleation of RecA.94 It was also described 
that the activity of the enzyme endo-a-D-mannosidase was 
affected by the buffer used. The higher activity was described 
when MES and MOPSO were used at pH 7.0; the enzyme activity 
was strongly reduced in HEPES or HEPPS buffer and wasessentially eliminated in Tris buffer.95 The inhibitory enzyme
effect of Tris was also described in the case of microperoxidase-
11 (MP-11).
Buffers are an integral part of the electrophoresis technique,
commonly used for the separation of nucleic acids and
proteins, since it requires a constant and precise pH value. Tris-
based buffers, such as Tris-acetate EDTA (TAE: 40 mmol l1
Tris-acetate; 1 mmol l1 EDTA; pH 8.3) and Tris-borate-EDTA
(TBE: 90 mmol l1 Tris; 90 mmol l1 boric acid, 2 mmol l1
EDTA; pH 8.3) are generally used in the electrophoretic sepa-
ration of DNA, using agarose gel.9 In the case of electrophoretic
RNA separation, agarose gels containing denaturing agents,
such as formaldehyde or glyoxal, have been used. Denaturing
agents decompose during electrophoresis, altering the pH of
the gel. In addition, RNA is unstable in slightly alkaline solu-
tions. Due to these reasons, MOPS buffer (pKa 7.2) has been
used for denaturing gel electrophoresis of RNA.9 The separation
of proteins is usually carried out using sodium dodecyl sulphate
(SDS) polyacrylamide gel electrophoresis (SDS–PAGE). For this
purpose, Tris-glycine (25 mmol l1 Tris; 250 mmol l1 glycine;
pH 8.3) or Tris-tricine (100 mmol l1 Tris; 100 mmol l1 tricine;
pH 8.2) are common buffers in SDS–PAGE.96
Buffer properties also affect protein, lipid and nucleic acid
extraction. For example, Davies and Goldberg97 have introduced
HEPES in the extraction buffer to prevent the damage of
proteins in red blood cells. HEPES was also employed with
glutamic acid in a xation method, which results in great
preservation of proteomic and nucleic content98 as well as in the
extraction of nucleic material.99 Fowler et al.100 have shown that
Tris buffer inhibits monoamine oxidase (MAO) activity in a non-
competitive manner; the authors warn against its use in MAO
extraction and estimation of activity. The concentration and pH 
of the buffer also play a role in the extraction protocols. It was 
described that 150 mmol l1 tricine buffer at pH 8.0 allowed the 
separation of metallothioneins by capillary zone 
electrophoresis.101
Neutral pH amine-based buffers, such as MOPS, HEPES, 
BES, TES and tricine, interact and form complexes with DNA.102 
It was found that the interaction of the buffer with the DNA 
affected the kinetic and binding parameters of cleavage of the 
plasmid pBR322 by the restriction endonuclease EcoRV. The 
authors found decreasing reaction rates from HEPES, TES to 
Tris. It was proposed that the modication of the binding of the 
enzyme to DNA was associated with the availability of proton-
ated amines of the buffer to act as counter ions to the DNA 
phosphate.103
Zwitterionic buffers inuence mRNA expression of in vitro 
produced bovine embryos. It was shown that transcription 
levels and embryo development were more profoundly affected 
by the use of TES than by HEPES and were least affected by 
MOPS.104
3.1.4. Inuence on DNA, RNA and protein measurement. 
Buffers should not absorb at wavelengths longer than 230 nm, 
since many spectrophotometric determinations of DNA, RNA 
and proteins are performed in this range of wavelengths. 
However, it is known that ACES displays a signicant absorp-
tion at 230 nm and ADA an absorption in UV range below 260 
nm.10
It is reported that Tris interferes with the Bradford protein 
assay. HEPES, PIPES, EPPS, bicine and MOPS interfere with 
Lowry protein determination; however, HEPES and MOPS do 
not interfere with Bradford or bicinchoninic acid 
assays.4,96,105,106
3.1.5. Impact of buffers in redox studies. MES does not 
form radical species. On the other hand, radical species can be 
formed from HEPES, PIPES and EPPS,4 which means that these 
buffers are not suitable for redox studies. It was also described 
that MOPS, MES, PIPES, HEPES and EPPS can be oxidized by 
H2O2; nevertheless, since buffer oxidation is slow, no signicant 
impact on biological/biochemical systems is expected to 
occur.107 MES, MOPS, HEPES and Tris retarded Fe(II) autoxida-
tion kinetics in the presence or absence of ferritin.108 In addi-
tion, it was described that MES, PIPES and HEPES interfere with 
phenolic oxidation by peroxidases.109 Formation of tricine-NO 
radicals was described in the presence of peroxide-forming 
enzymes;110 therefore, care should be taken with the use of tri-
cine if proteins with oxidase activity are present.
3.1.6. Effects of buffer in chromatographic separations. 
Some authors point out the relevance of the careful selection of 
the buffer used in chromatographic protocols, due to its 
possible interaction. Heinisch and Rocca111 studied the effects 
of several factors, including buffer types, such as Tris and BTP, 
at 30 mmol l1, on the retention of ionizable compounds in 
reversed-phase liquid chromatography. The authors showed 
that the type of the buffer could affect the performance of the 
separation. Borges and Collins112 described that buffers, such as 
tricine (pH 8.0, 20 mmol l1), affect the high-performance 
liquid chromatography (HPLC) stability and performance ofstationary phases [immobilized poly(methyloctylsiloxane) on
silica–PMOS–SiO2]. It was also shown that high pH values of the
mobile phase reduce the ion-exchange interactions between the
basic solutes and the stationary phase, resulting in lower
retention factors. Despite PMOS–SiO2 stationary phases dis-
playing low stability in alkaline mobile phases, the use of
buffers, such as tricine or Tris, gives unique selectivity proper-
ties to the mobile phase, making them promising for pharma-
ceutical analyses.112 Comparative to inorganic buffers, buffers
such as MES and Tris are adequate for capillary electro-
chromatography (CEC) due to their low ionic mobility.113 Jiskra
et al.114 studied the inuence of twelve commonly used organic
and inorganic buffers on the chromatographic behaviour of
HPLC and CEC. The authors found that inorganic buffers had
greater impact on the chromatographic behaviour compared to
organic buffers; within organic buffers, MES (1 mmol l1, pH
6.0) and Tris (0.5–10 mmol l1, pH 8.0) presented exceptional
behaviour.
3.1.7. Inuence of buffer complexation characteristics on
experimental results. There are a number of works in which,
although no initial consideration was given to the possible
interference of the buffer, the authors concluded that part of
their results may be conditioned by the metal–buffer pair used.
Wang et al.115 recognized that several components in their
chromatographic system may be competing for metal binding
with bis-Tris. Minami et al.116 found substantial differences
when different buffers, such as ADA and TAPS, were used for the
identication of metallothionein isoforms, using capillary zone
electrophoresis. BES and Tris were found to affect the results of
bacterial endotoxin tests in the presence of different metal
ions.72 In the study of photosystem II inhibition by Cu(II), it was
concluded that Tris, tricine and TES complexed with Cu(II), with
substantial effects on the nal results.7 The choice of buffer also
inuenced the determination of the thermodynamic parame-
ters associated with the interaction of alkaline metal ions with
citric acid.117 On the other hand, AMPSO and TAPSO have been
described to inhibit the activity of catalysts in chemical reaction
due to their capacity to bind with Cu(II), which was not a
problem when HEPES was used as a buffer.14 Nakano et al.,
while examining MOPSO, ACES, BES, MOPS, TES, HEPES and
3,3-dimethylglutaric acid (DGA) in an attempt to nd the
optimal conditions for the determination of Mn(II) by ow-
injection photometry, ultimately selected DGA, as it was the
only one to present no effects on the peaks obtained up to a
concentration of 1  102 M.118 BTP is recognized as a strong
coordinating buffer to Cu(II)46 and should be avoided in the use
of an assay for proteases, which uses a water soluble
uorescein-based ligand–Cu based method.119 In the study of
the interaction between succinate dehydrogenase and
ubiquinone-binding protein from succinate–ubiquinone
reductase, a decrease in protein activity was recorded as a
consequence of the buffer (HEPES, TES, and TAPS) inuence.120
Iron autoxidation rates are affected by the presence of buffers
(Tris, MES, MOPS and HEPES), which ultimately alter the
measured ferroxidase activity from horse spleen.108 In assessing
the possible effects of buffers on a size exclusion chromato-
graphic protocol’s mobile phase for the quantication of Cu, Fe
and Zn-containing metalloproteins, Tris, HEPES and MOPS 
showed different results from those obtained with phosphate 
buffered saline (PBS) solution for Fe and Zn-containing 
proteins.121
3.1.7.1. The knowledge of the complexing characteristics of the 
buffer. In many studies, experiments were conducted with metal 
ions in a buffered medium, where buffers known as being metal 
complexing ligands, as described in the previous section, were 
used. Some authors have taken into account this information 
and, accordingly, the free metal ion concentrations have been 
calculated. In order to study metal coordination to Zn(II) 
binding sites, Magyar and Godwin122 used soware for simu-
lating the speciation of metals with buffers, such as bis-Tris. A 
similar approach was undertaken by Amar et al.123 and Fayya-
zuddin et al.,124 who also performed simulations for Zn(II) and 
the buffers used, like ADA, using known stability constants. 
Sensi et al.125 also performed simulation calculations for MOPS, 
despite this no simulations have been performed for ADA with 
the metal in the system. Jenkins et al.126 took into consideration 
buffer complexation and made appropriate calculations 
regarding the TES–ATP–metal systems in their study. In the 
studies of inhibition of glycine receptors by Zn(II), Thio et al.127 
used tricine to chelate and control Zn and then calculated the 
free metal ion in solution. Stelzer et al.128 used computer 
programs to calculate free metal ion concentration where BES 
and Ca(II) were present in solution. Other researchers replaced 
buffers, as they were aware of possible complexation. For 
example, Atkinson et al.129 skipped the use of AMPD with Zn as 
it would complex.
3.1.7.2. Absence of information related to complexing proper-
ties. The major part of the studies found in the literature do not 
indicate if complexation between metal ions and the buffer(s) 
used has been taken into account. Reasons for that can be that 
the authors skipped its writing, neglected it or were unaware of 
the possible complexation effects that buffers might have. For 
instance, Bayen et al.130 studied Cd speciation and bioavail-
ability in the presence of several buffers (MES, MOPS, TAPS, 
AMPSO, HEPES and ACES) to test the pH effect. In this work, 
buffers were used as “non-complexing” agents although 
stability constants for complexes between Cd and TAPS, AMPSO 
and ACES are described in the literature.
There is also the case where no complex stability constants 
are available in the literature and therefore, no complexation 
could be predicted. These situations usually involve metal ions 
not commonly studied in speciation works or metals, such as 
Ca(II) or Mg(II). For example, Ono et al.131 studied the variation 
of photosynthetic oxygen evolution when Ca(II) was replaced by 
K(I), Rb(I) and Cs(I), in the presence of bis-Tris and MES. In 
turn, Wheatley et al.132 used bis-Tris and TES in the crystalli-
zation and kinetics of b-galactosidase, an enzyme with Mg(II) 
and Na(I) active centres, respectively, while Beeler et al.133 
studied rat skeletal Mg(II)-ATPase in the presence of ADA. In 
these and other similar situations, buffer complexation is 
unknown. If it occurs, no impact on the studies performed was 
considered.
3.1.7.3. Presence of other ligands in solution. In several 
studies, some of the components present in the medium understudy have themselves high complexing capabilities and buffer
interference is thought to be simply nonexistent. These studies
involve proteins with heme groups,134–136 Zn-nger motifs,137–139
metalloproteins116,133,140–142 and/or other complexing agents in
solution.81,143–145 In fact, the concentrations of the compounds
used, and most importantly the ratio of the buffer concentra-
tion to the complexing compound concentration in the
medium, are within values that support the idea that no inter-
ference of the buffer occurs.
In other studies, the concentrations of metal, buffer and/or
component with complexing properties under study may raise
doubts regarding the possible interference of buffers. Even if
the affinity of the biological component to the metal is much
larger than that of the buffer to the metal, a substantial
difference in concentration may favour the formation of
metal–buffer complexes due to a mass effect. There are some
works that can be mentioned as examples of this situation.
Juillard et al.146 used about 1000 times more buffer (bis-Tris)
than ferric heme and apomyoglobin in their binding studies,
whilst Seto et al.147 used 40 times more buffer than luciferin
and EDTA; in this study, a sensitive bioluminescent enzyme
immunoassay based on luciferin, where Mg(II) plays a vital
role, was used. For BTP buffer, which is a strongly complexing
ligand, some more examples are found in the literature. For
example, Ejnik et al.148 used a BTP buffer concentration about
2500 times larger than the concentration of the apometallo-
thionein domains. Additionally, in Kanaori’s study related to
the effect of Cd on the histidinol dehydrogenase metal
binding, a BTP concentration several thousand times larger
than that of histidinol was used.149 Other situations where the
concentration of buffer used is substantially higher than that
of existing components under study can be found in the
literature related to other buffers such as TES,150 Tris,136
TEA,151,152 TAPS153 and AMPSO.154 Even though we cannot
denitively assert that buffer interferences exist in such
studies, a cautious analysis of the results should be
considered.3.2. HEPES, MES and other Good’s buffers
HEPES is a buffer widely used. It is a non to very weak com-
plexing agent, as noted in the previous section. Thus, it is
suitable for most studies with metal ions. In fact, it is widely
used throughout all elds of research, such as biomolec-
ular,138,139,155–157 biochemical,94,121,158–160 toxicological,161–163
cellular79,125,164,165 and environmental138,157,165,166 studies.
However, attention should be paid to other possible interfer-
ences from HEPES, such as interferences in oxidation reac-
tions,107,109,166 interferences with DNA102 and other biological
molecules.3,92,93,103
Another option is MES, which is also a non-complexing
ligand and has been widely used.157,167–173 As it was previously
discussed in Section 2, there are other possible buffers, such as
MOPS or PIPES, or even MOPSO, HEPPSO, POPSO and EPPS.
For each one, a careful research should be made in order to
ensure that no effects occur in studies where these buffers are
intended to be used.
4. Suitability of pH buffer use based
on metal complexation
Based on the analyses of the information described in the 
previous sections, the stability constants found in the literature, 
together with a comprehensive study of chemical speciation 
simulation for all relevant metal–buffer pairs, a table containing 
qualitative information of the complexation magnitude 
strength between the different buffers and metals was elabo-
rated (Table 3). Metal chemical speciation calculations wereTable 3 Overview of the complexation magnitude strength between th
a Final remarks regarding the overall suitability of the buffer. Suitable: (+
yellow – light complexation; green – no complexation; blue – data not in ag
where the complexation models and references are found.performed using the computer program MINEQL+ Version
4.5,174 which generates chemical equilibrium concentrations of
all species being considered in the model by the program
reactions (data not shown). In a general scenario, from the
analysis of Table 3, we can say that fourteen buffers arise as best
candidates (Fig. 1): MES, PIPES, MOPSO, MOPS, HEPES, MOBS,
HEPPSO, POPSO, EPPS, HEPBS, CHES, CAPSO, CAPS and CABS.
As previously detailed, some studies describe complexation
of MES with metal ions while others support that MES is a non-
complexing agent. However, based on the analytical techniques
employed in those studies, in the data analyses and behavioure different metal–buffer pairsc
); not suitable: (). b Unpublished results. c Red – strong complexation;
reement. For further information, see the ESI† supplied with this review
with some metals, we regard MES as a suitable compound for 
buffering within its pH buffer range (5.50–6.70). In a similar 
way, for PIPES, as previously noted, although complexation is 
reported, we also regard that in light of the data presented in 
the literature it is very likely that PIPES does not complex with 
metal ions, or if it does, complexation occurs to very little extent. 
Given these reasons, we nd PIPES as a possible buffer for use 
within its pH buffering range (6.10–7.50). For MOPSO and 
MOPS, the same arguments as for MES are valid and, therefore, 
these buffers can be included in our free complexation list, 
providing an option for pH between 6.20 to 7.60 and between 
6.50 to 7.90, respectively. By analyzing the literature about 
HEPES, a similar scenario to that of PIPES is found and, we 
regard that HEPES is generally described in the literature as a 
non-complexing buffer and thus suitable to be used in solutions 
with metal ions. In the case of HEPPSO and Cu(II), special 
attention is needed if one wants to use it to buffer Cu(II) solu-
tions. For EPPS and HEPBS, based on the analyses of the data 
available, we strongly regard that it does not complex with 
metals and so, they are possibly good buffers for pH ranges of 
7.30–8.70 and 7.60–9.00 respectively. As for MOBS, POPSO, 
CAPSO, CAPS, CHES and CABS, for which no or only very faint 
complexation was described, these can be considered as good 
buffering agents to be used in solutions containing metal ions. 
However, these buffers, with the exception of MOBS and 
POPSO, have a higher buffer range (8.30–11.40), which makes 
them an option only for specic studies where higher pH is 
demanded. Although no stability constants were determined, 
POPSO was shown to bind with Cu(II) and therefore, in this 
particular case, special care is needed.
The buffers reported above are the most adequate for studies 
free of metal interferences but other buffers are commercialized 
and may be used as well. Metal–buffer pairs, which form weak 
complexes, may be used when other components, that have 
great metal stability constants, are present in solution. In this 
case, metal interferences from the buffer, due to complexation, 
are not predictable. Nevertheless, if possible, a speciation study 
with all elements present in solution should be made in order to 
ensure such a claim. In other cases, where complex stability 
constants are lower for the components under study and higher 
for the metal–buffer complex, speciation studies should be 
mandatory to ensure a proper conclusion from the data 
obtained in the work.
5. Concluding remarks
Considering all the facts described above and given the large 
number of stability constants determined for the metal–buffer 
systems, an imperative need, predicted long time ago by Good, 
arises: the metal–buffer equilibrium, used in any experiment, 
should be known and be a key part of the nal results and 
conclusions of the work. In most circumstances, the effects may 
be negligible, but nevertheless, wrong conclusions may be 
taken from the results obtained, especially when the stability 
constants for the metal–buffer are strong. In such cases, two 
strategies may be adopted: (1) the use of different buffers in 
individual trials in such a way that differences in the bufferusage may be deduced, if any, or (2) if the use of more than one
buffer or running more than one experiment is out of question,
the use of a known non-complexing buffer, such as PIPES,
HEPES, MES or MOPS, as a buffer agent in the experiments.
To conclude, searching for a proper buffer for a given
experiment should be more than just looking for the appro-
priate buffering pH range. All other known buffer interactions,
such as metal–buffer complexation and biological effects
should also be taken into account.Conflict of interest
The authors declare that this article content has no conicts of
interest.AcronymsACES N-(2-Acetamido)-2-aminoethanesulfonic acid
N-(Carbamoylmethyl)-2-aminoethanesulfonic acid
N-(Carbamoylmethyl)taurine
2-[(2-Amino-2-oxoethyl)amino]ethanesulfonic acid*ADA N-(2-Acetamido)iminodiacetic acid
N-(Carbamoylmethyl)iminodiacetic acid
2,20-[(2-Amino-2-oxoethyl)imino]diacetic acid*AMP 2-Amino-2-methyl-1-propanediol
Isobutanol-2-amine
b-Aminoisobutyl alcohol
2-Amino-2-methyl-1-propanol*AMPD 2-Amino-2-methyl-1,3-propanediol*
2-Amino-2-methylpropane-1,3-diolAMPSO 3-([1,1-Dimethyl-2-hydroxyethyl]amino)-2-
hydroxypropanesulfonic acid
N-(1,1-Dimethyl-2-hydroxyethyl)-3-amino-2-
hydroxypropanesulfonic acid
2-Hydroxy-3-[(1-hydroxy-2-methyl-2-propanyl)amino]-1-
propanesulfonic acid*BES N,N-Bis(2-hydroxyethyl)-2-aminoethanesulfonic acid
N,N-Bis(2-hydroxyethyl)taurine
2-[Bis(2-hydroxyethyl)amino]ethanesulfonic acid*Bicine N,N-Bis(2-hydroxyethyl)glycine*
(Bis(2-hydroxyethyl)amino)acetic acidBis-Tris 2,2-Bis(hydroxymethyl)-2,20,200-nitrilotriethanol
Bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methane
2-[Bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)-1,3-
propanediol*
1,3-Propanediol,2-[bis(2-hydroxyethyl)amino]-2-
(hydroxymethyl)BTP Bis-Tris propane
1,3-Bis[tris(hydroxymethyl)methylamino]propane
2,20-(1,3-Propanediyldiimino)bis[2-(hydroxymethyl)-1,3-
propanediol]*
1,3-Propanediol,2,20-(1,3-propanediyldiimino)bis[2-
(hydroxymethyl)CABS 4-(Cyclohexylamino)-1-butanesulfonic acid*
4-(Cyclohexylamino)butanesulfonic acidCAPS 3-(Cyclohexylamino)-1-propanesulfonic acid*
3-(Cyclohexylamino)propanesulfonic acidCAPSO 3-(Cyclohexylamino)-2-hydroxy-1-propanesulfonic acid*
1-Propanesulfonic acid,3-(cyclohexylamino)-2-hydroxyCHES 2-(Cyclohexylamino)ethanesulfonic acid*
2-(N-Cyclohexylamino)ethanesulfonic acidDIPSO 3-(N,N-Bis[2-hydroxyethyl]amino)-2-hydroxypropanesulfonic
acid
N,N-Bis(2-hydroxyethyl)-3-amino-2-hydroxypropanesulfonic
acid
3-[Bis(2-hydroxyethyl)amino]-2-hydroxy-1-propanesulfonic
acid*EPPS/
HEPPS
4
4
-(2-Hydroxyethyl)-1-piperazinepropanesulfonic acid
-(2-Hydroxyethyl)piperazine-1-propanesulfonic acid
N-(2-Hydroxyethyl)piperazine-N0-(3-propanesulfonic acid)
3-[4-(2-Hydroxyethyl)-1-piperazinyl]-1-propanesulfonic acid*HEPBS N-(2-Hydroxyethyl)piperazine-N0-(4-butanesulfonic acid)
4-[4-(2-Hydroxyethyl)-1-piperazinyl]-1-butanesulfonic acid*
1-Piperazinebutanesulfonic acid,4-(2-hydroxyethyl)HEPES 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid
N-(2-Hydroxyethyl)piperazine-N0-(2-ethanesulfonic acid)
2-[4-(2-Hydroxyethyl)-1-piperazinyl]ethanesulfonic acid*HEPPSO N-(2-Hydroxyethyl)piperazine-N0-(2-hydroxypropanesulfonic
acid)
4-(2-Hydroxyethyl)piperazine-1-(2-hydroxypropanesulfonic
acid)
2-Hydroxy-3-[4-(2-hydroxyethyl)-1-piperazinyl]-1-
propanesulfonic acid*MES 2-(N-Morpholino)ethanesulfonic acid
4-Morpholineethanesulfonic acid
2-(4-Morpholinyl)ethanesulfonic acid*MOBS 4-(N-Morpholino)butanesulfonic acid
4-(4-Morpholinyl)-1-butanesulfonic acid*MOPS 3-(N-Morpholino)propanesulfonic acid
4-Morpholinepropanesulfonic acid
3-(4-Morpholinyl)-1-propanesulfonic acid*MOPSO b-Hydroxy-4-morpholinepropanesulfonic acid
3-Morpholino-2-hydroxypropanesulfonic acid
2-Hydroxy-3-(4-morpholinyl)-1-propanesulfonic acid*PIPES 1,4-Piperazinediethanesulfonic acid
Piperazine-1,4-bis(2-ethanesulfonic acid)
Piperazine-N,N0-bis(2-ethanesulfonic acid)
2,20-(1,4-Piperazinediyl)diethanesulfonic acid*POPSO Piperazine-1,4-bis(2-hydroxypropanesulfonic acid)
Piperazine-N,N0-bis(2-hydroxypropanesulfonic acid)
3,30-(1,4-Piperazinediyl)bis(2-hydroxy-1-propanesulfonic
acid)*TABS N-Tris(hydroxymethyl)methyl-4-aminobutanesulfonic acid
4-{[1,3-Dihydroxy-2-(hydroxymethyl)-2-propanyl]amino}-1-
butanesulfonic acid*TAPS [(2-Hydroxy-1,1-bis(hydroxymethyl)ethyl)amino]-1-
propanesulfonic acid
N-[Tris(hydroxymethyl)methyl]-3-aminopropanesulfonic acid
3-{[1,3-Dihydroxy-2-(hydroxymethyl)-2-propanyl]amino}-1-
propanesulfonic acid*TAPSO 2-Hydroxy-3-[tris(hydroxymethyl)methylamino]-1-
propanesulfonic acid
N-[Tris(hydroxymethyl)methyl]-3-amino-2-
hydroxypropanesulfonic acid
3-{[1,3-Dihydroxy-2-(hydroxymethyl)-2-propanyl]amino}-2-
hydroxy-1-propanesulfonic acid*TEA Triethanolamine
Tris(2-hydroxyethyl)amine
2,20,200-Nitrilotriethanol*TES 2-[(2-Hydroxy-1,1-bis(hydroxymethyl)ethyl)amino]
ethanesulfonic acid
N-[Tris(hydroxymethyl)methyl]-2-aminoethanesulfonic acid
2-{[1,3-Dihydroxy-2-(hydroxymethyl)-2-propanyl]amino}
ethanesulfonic acid*Tricine N-[Tris(hydroxymethyl)methyl]glycine
N-[1,3-Dihydroxy-2-(hydroxymethyl)-2-propanyl]glycine*Tris 2-Amino-2-(hydroxymethyl)-1,3-propanediol*
THAM
Tris base
Tris(hydroxymethyl)aminomethane
Trometamol*Systematic name according to IUPAC as described in the online
ChemSpider database from the Royal Society of Chemistry.190
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